InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (3 ops.)
Browse the detailed record of transactions filed by Loose Christopher R., Directeur Scientifique. Officer active across 1 companies, notably Frequency Therapeutics, Inc.. Cumulatively, 4 reports have been logged. Total volume traded: €10k. The latest transaction was disclosed on 18 February 2022 (Cession). Regulator: SEC (Form 4). All data is free.
Declarations4 total
€3,319974 shares@ €3.407433.3% of flow
Common Stock
SEC:0001127602-22-006339:0·
€3,319851 shares@ €3.8999100.0% of flow
Common Stock
SEC:0001127602-22-005752·
€3,319851 shares@ €3.899933.3% of flow
Common Stock
SEC:0001127602-22-005752:0·
15,000 shares
Common Stock
SEC:0001127602-22-005331:0·
4 of 4 declarations
About Loose Christopher R.
Christopher R. Loose is the Chief Scientific Officer of Frequency Therapeutics, Inc. In this role, he is responsible for scientific leadership and innovation within the company. Christopher plays a key role in developing new therapies and technologies, thereby contributing to advancements in science and health. His expertise is essential in positioning Frequency Therapeutics as a leader in the biotechnology field.
